Penumbra, Inc. Common Stock (PEN)
Frequently Asked Questions About Penumbra, Inc. Common Stock (PEN)
Can you describe Penumbra's approach to regulatory compliance?
Penumbra adheres to strict regulatory compliance protocols, ensuring that all their products meet the rigorous standards set by governing bodies such as the FDA and CE marking in Europe. The company's quality management systems are designed to incorporate feedback from both regulatory agencies and healthcare providers to ensure that their devices are safe and effective.
How does Penumbra engage with the community?
Penumbra engages with the community through various outreach and partnership initiatives, including collaborations with healthcare providers and educational programs aimed at raising awareness about vascular and neurological conditions. Their goal is to foster better understanding and promote advancements in treatment and care.
How does Penumbra ensure product quality?
To ensure product quality, Penumbra maintains a comprehensive quality management system that encompasses every aspect of its operations, from design and manufacturing to clinical evaluation. This includes stringent testing processes, regular audits, and a commitment to continuous improvement based on feedback and technological advancements.
How does Penumbra, Inc. contribute to medical innovation?
Penumbra, Inc. contributes to medical innovation through a continuous investment in research and development. The company collaborates with healthcare professionals and leverages cutting-edge technology to design and produce devices that address unmet clinical needs, ensuring that advancements in medical technology translate into better patient care.
How has Penumbra performed financially?
Penumbra has demonstrated strong financial performance, characterized by consistent revenue growth and increased market share since its initial public offering. The company's innovative product offerings and strategic investments in R&D have contributed to solid fiscal results, appealing to investors looking for growth in the medical device sector.
Is Penumbra, Inc. publicly traded?
Yes, Penumbra, Inc. is publicly traded on the New York Stock Exchange under the ticker symbol PEN. The company went public in 2016 and has since been subject to the regulations and reporting requirements associated with being a publicly listed entity.
What does Penumbra, Inc. do?
Penumbra, Inc. is a global healthcare company focused on developing innovative therapeutic solutions for people suffering from disease. The company specializes in neuro and vascular intervention products, including devices for treating conditions such as ischemic stroke and pulmonary embolism. Their mission is to help healthcare professionals achieve the best possible outcomes for their patients.
What is Penumbra's corporate mission?
Penumbra's corporate mission is to innovate and develop medical solutions that improve patient lives. They aim to radically change the way diseases are treated through advancements in technology and design, ensuring that their products enhance clinical effectiveness and patient safety.
What is the main focus of Penumbra's research and development?
The main focus of Penumbra's research and development is the creation of innovative devices that tackle complex medical challenges in the neurovascular space. Their R&D efforts are centered around enhancing existing products, exploring new therapeutic areas, and developing groundbreaking technologies that can significantly improve patient outcomes in critical care.
What markets does Penumbra, Inc. serve?
Penumbra, Inc. serves both the domestic U.S. market as well as international markets across Europe, Asia, and other regions. Their focus on global expansion allows them to reach diverse healthcare systems, thereby contributing to the management of neurological and vascular diseases on a larger scale.
What recent developments has Penumbra, Inc. announced?
Penumbra, Inc. has recently announced several product launches and collaborations aimed at advancing their portfolio in neuro and vascular care. These developments often include enhancements in their existing products, the introduction of new technologies, or partnerships aimed at expanding their reach and clinical applications.
What role does sustainability play in Penumbra's operations?
Sustainability is an integral aspect of Penumbra's operations, as the company seeks to minimize its environmental impact through responsible manufacturing processes and waste management practices. Additionally, they are committed to creating devices that not only benefit patient health but also contribute to overall healthcare system sustainability.
What sets Penumbra apart from its competitors?
Penumbra stands out among its competitors due to its commitment to developing user-centric devices that emphasize simplicity, efficacy, and safety. The company leverages a deep understanding of clinical needs and combines it with rigorous engineering to create solutions that enhance procedural outcomes in complex interventions.
What strategic initiatives is Penumbra currently pursuing?
Currently, Penumbra is pursuing strategic initiatives centered around expanding its product portfolio, enhancing research collaborations, and increasing market penetration in emerging areas of healthcare. This includes exploring new therapeutic markets and optimizing their supply chain to respond to global demands effectively.
What types of products does Penumbra manufacture?
Penumbra manufactures a range of medical devices, including but not limited to neuro vascular access and embolization devices. Their flagship products include aspiration and stent-retriever systems designed for the removal of blood clots, which are critical in treating conditions like stroke.
When was Penumbra, Inc. founded?
Penumbra, Inc. was founded in 2004. Since its inception, the company has dedicated itself to advancing medical technologies, focusing on developing devices that are designed to improve patient outcomes in various treatment scenarios.
Where is Penumbra, Inc. headquartered?
Penumbra, Inc. is headquartered in Alameda, California. This strategic location allows the company to be at the heart of a vibrant medical technology ecosystem and access some of the leading healthcare institutions, engineering talent, and research facilities.
Who are the primary customers of Penumbra, Inc.?
The primary customers of Penumbra, Inc. include hospitals, healthcare providers, and medical professionals specializing in cardiovascular and neurological care. The company's products are geared toward interventional radiologists, neurosurgeons, and other clinicians involved in treating conditions requiring advanced medical interventions.
Who leads Penumbra, Inc.?
Penumbra, Inc. is led by a team of experienced professionals including CEO Adam Elsesser, who co-founded the company. The leadership team comprises experts with extensive backgrounds in engineering, medicine, and operational management, driving the company's vision and strategic growth initiatives.
What is the current price of Penumbra, Inc. Common Stock?
The current price of Penumbra, Inc. Common Stock is 262.28
When was Penumbra, Inc. Common Stock last traded?
The last trade of Penumbra, Inc. Common Stock was at 4:10 pm EDT on April 4th, 2025
What is the market capitalization of Penumbra, Inc. Common Stock?
The market capitalization of Penumbra, Inc. Common Stock is 9.59B
How many shares of Penumbra, Inc. Common Stock are outstanding?
Penumbra, Inc. Common Stock has 36.58M shares outstanding.